Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15‐month‐old child

@article{Hommann2002ApplicationOM,
  title={Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15‐month‐old child},
  author={Merten Hommann and L. B. Kasakow and Justin Geoghegan and Arno Kornberg and Uwe Schotte and Bernd Gruhn and Dietlinde Fuchs and Johann Hermann and Felix Zintl and Johannes Scheele},
  journal={Pediatric Transplantation},
  year={2002},
  volume={6}
}
Abstract: Molecular Adsorbent Recirculating System (MARS) is a blood‐filtering system designed to provide biological artificial liver support. We describe its use in a small child to illustrate its effectiveness and practicality in this age group. A 15‐month‐old male underwent split liver transplantation for acute liver failure following bone marrow transplantation. After development of graft dysfunction we instituted MARS‐dialysis. MARS therapy led to a dramatic fall in serum bilirubin and… 
Experience with molecular adsorbent recirculating system treatment in 20 children listed for high‐urgency liver transplantation
  • W. Lexmond, C. V. van Dael, +5 authors M. Kömhoff
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2015
TLDR
The data demonstrate the safety of MARS even in the most severely ill patients awaiting LT, but strategies that promote the more rapid and widespread availability of high‐quality donor organs remain of critical importance for improving patient survival in cases of severe acute liver failure.
Value of albumin dialysis therapy in severe liver insufficiency
Abstract A blood purification system, molecular adsorbents re‐circulating system (MARS), is based on the removal of both protein‐bound and water‐soluble substances and toxins in the liver. We treated
Extracorporeal Liver Support Systems in Paediatric Liver Failure
  • V. Jain, A. Dhawan
  • Medicine
    Journal of pediatric gastroenterology and nutrition
  • 2017
TLDR
Current practices of extracorporeal liver support systems are critically appraised to help determine efficacy in paediatric liver failure.
Value of albumin dialysis therapy in severe liver insufficiency
TLDR
MARS is a promising therapy for ALF, allowing the patient’s own liver to recover or allowing enough time to find a liver graft, but did not observe much benefit in patients with severe acute-on-chronic liver failure (AcoChr) who did not undergo liver transplantation.
Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation – a pilot study
  • J. Choi, S. Bae, +7 authors D. Kim
  • Medicine
    Liver international : official journal of the International Association for the Study of the Liver
  • 2005
Abstract: Purpose: The aim of this prospective study was to evaluate the effectiveness of preconditioning molecular adsorbent recirculating system (MARS) treatment on patients with acute‐on‐chronic
Is It Right to Promote Living Donor Liver Transplantation for Fulminant Hepatic Failure in Pediatric Recipients?
  • R. Reding
  • Medicine
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2005
TLDR
The ethical soundness of living parental donor LT for FHF is discussed, with emphasis to the type of medical context, with or without access to an efficient emergency postmortem organ sharing system.
The future of liver transplantation.
TLDR
The main investigative efforts in liver transplantation have been directed as follows: attenuation of disproprortion between the numbers of available liver grafts versus waiting list recipients, by increasing the donor pool applying bioartificial support systems, or rendering grafts compatible by the use of stem cells.
Liver support for fulminant hepatic failure: Is it time to use the Molecular Adsorbents Recycling System in children?*
  • P. Tissières, J. Sasbón, D. Devictor
  • Medicine
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
  • 2005
TLDR
Although promising preliminary results suggest that MARS may have a significant position in the therapeutic arsenal for FHF, no sufficient data exist to justify its use in children, and the indications of this expensive technique in children with FHF are limited.
Artificial liver support systems.
  • J. George
  • Medicine
    The Journal of the Association of Physicians of India
  • 2004
TLDR
The various methods of extracorporeal liver support that are available at present are assessed and those that appear to be promising are described.
New Management Options for End-Stage Chronic Liver Disease and Acute Liver Failure
TLDR
The Molecular Adsorbent Recirculating System (MARS® or albumin dialysis) is the liver support system most frequently used worldwide in adults and appears to offer distinct advantages over hepatocyte-based systems.
...
1
2
3
...

References

SHOWING 1-10 OF 13 REFERENCES
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial
  • S. Mitzner, J. Stange, +14 authors R. Schmidt
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2000
TLDR
It is concluded that the removal of albumin‐bound substances with the MARS method can contribute to the treatment of type I HRS.
What should we expect from a bioartificial liver in fulminant hepatic failure?
TLDR
Because of donor organ shortage and urgency, a bioartificial liver could act as an effective bridge to liver transplantation in patients with fulminant hepatic failure.
Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.
TLDR
A new membrane separation system that is nearly impermeable to proteins but enables the exchange of water soluble and protein bound toxins by a special membrane and a recycled protein containing dialysate is described.
Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins.
BACKGROUND Acute liver failure may be the first manifestation of Wilson disease. If copper elimination fails, liver transplantation is the only remaining therapeutic option. Albumin dialysis, a new
Neurological and psychological sequelae in transplant recipients after bridging with the bioartificial liver.
TLDR
Over a 2-year period, nine patients were bridged to transplantation using the BAL to keep them neurologically intact prior to surgery, and one patient had decerebrate posturing with a peak ICP of 50 mmHg.
Use of bioartificial and artificial liver support devices.
TLDR
A better understanding of the effects of these devices on the metabolic function of the damaged liver and the recovery process will be essential in the further development and design of effective systems.
A Carrier-Mediated Transport of Toxins in a Hybrid Membrane. Safety Barrier between a Patients Blood and a Bioartificial Liver
TLDR
The presented hybrid membrane may be used like an “intellegent membrane” as a safety barrier between the patients blood and cell devices and a significant reduction of protein bound toxins and a transport of metabolically relevant solutes, like amino acids, was shown.
A new procedure for the removal of protein bound drugs and toxins.
TLDR
The system effectively removed strongly albumin bound toxins like unconjugated bilirubin or free fatty acids from plasma and blood in vitro and in vivo and therefore could be considered a possible therapeutic means for the treatment of acute liver failure or acute and chronic intoxications with album in bound toxins, e.g., in drug overdose or chronic renal failure.
Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.
TLDR
This work presents an alternative method that enables the dialyzability of albumin-bound toxins from plasma by the use of a high-flux dialyzer and an albumin solution circulating on the dialysate side to increase selectively the affinity for albumin, which resulted in effective removal of unconjugated bilirubin.
Characteristics of an Albumin Dialysate Hemodiafiltration System for the Clearance of Unconjugated Bilirubin
TLDR
The clearance of unconjugated bilirubin is greatly enhanced with the use of albumin containing dialysates when compared to traditional crystalloid hemodiafiltration, is greater at lower pH, and seems to be unaffected by temperature.
...
1
2
...